Dear health care system,

you need to care for everybody, be affordable and available at all times. Yet with the numbers of pathogens resistant against all known antibiotics growing, how can you make sure to have an effective care for patients with infectious diseases in the next generation? By investing in fast diagnostics, and allowing the prescription and sale of antibiotics only after a positive identification of the bacteria and its resistance profile, you can reduce the consumption of antibiotics. This will lower the selective pressure on bacteria and stop the spread of resistance. This way we can keep our antibiotics working for future generations. Clemedi wants to be a part in this, by streamlining the current workflow and bring the field of micobiology into the age of molecular biology.